SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?


To: rkrw who wrote (6022)11/20/2004 10:28:33 AM
From: fred hayes  Read Replies (2) | Respond to of 10345
 
>Tarceva label is very good<: Huh? When approval was first announced, OSIP ran up several points (if after hours counts). Only after the detail of the label was out did it tank 10 percent or so (in addition to giving up the early gains). You may be able to argue about a good label based on some technical criteria, but it sure looks like the perception of a more limited market drove the downturn.

fred hayes